MedPath

NP Thyroid 15

NP Thyroid (THYROID TABLETS, USP) Rx Only

Approved
Approval ID

647df9e7-5234-4de6-bce5-bb2cf0c5c7e6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 9, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LEVOTHYROXINE, LIOTHYRONINE

PRODUCT DETAILS

NDC Product Code63629-8265
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationORAL
Effective DateNovember 14, 2018
Generic NameLEVOTHYROXINE, LIOTHYRONINE

INGREDIENTS (6)

CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083G
Classification: IACT
MINERAL OILInactive
Code: T5L8T28FGP
Classification: IACT
MALTODEXTRINInactive
Code: 7CVR7L4A2D
Classification: IACT
LEVOTHYROXINEActive
Quantity: 9.5 ug in 1 1
Code: Q51BO43MG4
Classification: ACTIB
LIOTHYRONINEActive
Quantity: 2.25 ug in 1 1
Code: 06LU7C9H1V
Classification: ACTIB
© Copyright 2025. All Rights Reserved by MedPath
NP Thyroid 15 - FDA Approval | MedPath